Biomarin Pharmaceutical Inc at Piper Sandler Healthcare Conference (Virtual) Transcript
Great. Well, let's go ahead and get started with our next session. Thanks, everybody, for dialing in. This is the last day, I believe, of the Piper Sandler 33rd Annual Healthcare Conference. I appreciate everybody dialing in.
We have with us our next presenter, which is BioMarin. We have with us Chairman and CEO, J.J. Bienaime; CFO, Brian Mueller; and Chief Commercial Officer, Jeff Ajer.
So this is meant to be a participative session. So folks, I think there's an option for you in your Zoom window to ask a question, if you want to raise your hand and ask a question, that way you can do it or if you don't want to do it that way, there's always the old school option. You can just e-mail me. Hit me an e-mail, and I'll make sure your question gets answered.
So J.J., I think you had a couple of minutes of intro commentary that you wanted to make. So I'll let you do that. Please take it away, and then we'll jump into questions.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |